Chuanbao Zhang

Chuanbao Zhang

Auto-generated profile, based on publicly available information

Chuanbao Zhang

National Center for Clinical Laboratories, Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, P. R. China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2024 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
CSChen Shan
Chen Shan
CZChao Zhang
Chao Zhang
CZChuanbao Zhang
Chuanbao Zhang

22 October 2020 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
CZChao Zhang
Chao Zhang
JZJiangtao Zhang
Jiangtao Zhang
JWJing Wang
Jing Wang
YYYing Yan
Ying Yan
CZChuanbao Zhang
Chuanbao Zhang
Previous studies have found that alpha‐fetoprotein (AFP) can promote the proliferation of hepatoma cells and accelerate the progression of hepatocellular carcinoma (HCC). However, the exact mechanism of action remains unclear. Recent bioinformatics studies have predicted the possible interaction between AFP and retinoic acid receptors (RARs). Thus, the purpose of this study was to investigate the molecular mechanism through which AFP promotes tumour cell proliferation by interfering with the RA‐RAR signal pathway. Our data indicated that AFP could significantly promote the proliferation and weaken ATRA‐induced apoptosis of hepatoma cells. Besides, cytoplasmic AFP interacts with RAR, disrupting its entrance into the nucleus, which in turn affects the expression of the Bcl‐2 gene. In addition, knockdown of AFP in HepG2 cells was synchronously associated with an incremental increase of RAR binding to DNA, as well as down‐regulation of Bcl‐2; the opposite effect was observed in AFP gene‐transfected HLE cells. Moreover, a similar effect of AFP was detected in tumour tissues with high serum AFP, but not in adjacent non‐cancerous liver tissues, or HCC tissues with low serum AFP levels. These results indicate that AFP acts as signalling molecule and prevents RAR from entering into the nucleus by interacting with RAR, thereby promoting the expression of Bcl‐2. Our data reveal a novel mechanism through which AFP regulates Bcl‐2 expression and further suggest that AFP may be used as a novel target for treating HCC.

13 October 2021 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
ZLZhenni Liu
Zhenni Liu
QLQingxiang Liu
Qingxiang Liu
YDYuhang Deng
Yuhang Deng
HZHaijian Zhao
Haijian Zhao
JZJie Zeng
Jie Zeng
CZChuanbao Zhang
Chuanbao Zhang

22 August 2022 in iScience
Verified
Journal Article
Open access
CZChao Zhang
Chao Zhang
XWXin Wang
Xin Wang
CZChuanbao Zhang
Chuanbao Zhang
Icaritin has shown antitumor activity in a variety of human solid tumors and myeloid leukemia cells. However, the direct target of icaritin and the underlying mechanisms remain unclear. In our study, CDK2 was found to be a direct target of icaritin in tumor cells. On one hand, icaritin interacted with CDK2 and interfered with CDK2/CyclinE complex formation, resulting in downregulation of CDK2 activity as illustrated with attenuated phosphorylation of FOXO1, Rb, and P27, and E2F/Rb dissociation. On the other hand, icaritin reduced the stability and translation efficiency of CDK2-mRNA by modulating microRNA-597 expression. To be of functional importance, icaritin inhibited proliferation and promoted apoptosis of tumor cells in vitro and in vivo, which was consistent with CDK2 inhibitors—k03861. Our data revealed CDK2 as the direct target of icaritin for its antitumor effects, which may suggest new therapeutics of icaritin or combinational therapeutics involving both icaritin and CDK2 inhibitors for cancers.

26 February 2019 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
YWYufei Wang
Yufei Wang
TZTianjiao Zhang
Tianjiao Zhang
HZHaijian Zhao
Haijian Zhao
WZWeiyan Zhou
Weiyan Zhou
JZJie Zeng
Jie Zeng
WCWenxiang Chen
Wenxiang Chen

30 November 2021 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
LJLizi Jin
Lizi Jin
XHXueyan Han
Xueyan Han
FHFalin He
Falin He
CZChuanbao Zhang
Chuanbao Zhang
Knowing the scale of rare inborn errors is important for screening and resource allocation. Evidence on the prevalence of methylmalonic acidemia (MMA) among newborns and the clinical-suspected popu...